Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Brufman

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Oncology|January 1, 1984
Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumorsG Brufman, J Halpern, A Sulkes, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Fetal hemoglobin screening in whole blood and in plasma of cancer patientsM Wolk, M Kieselstein, C G Ben-Dor, et al.
Oncology|January 1, 1989
Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover studyE Gez, R Ben-Yosef, R Catane, et al.
Israel Journal of Medical Sciences|September 1, 1981
Immune complex-like materials in sera of patients with breast cancer: detection by complement-consumption assayD Sulitzeanu, O Asaf, S Biran, et al.
Breast Cancer Research and Treatment|January 1, 1993
The effect of tamoxifen on the endometriumB Uziely, A Lewin, G Brufman, et al.
Cancer|December 15, 1981
Comparison of the response to PHA and suppressor macrophage function in different age groups of cancer patients and healthy controlsA J Treves, A Horowitz, S Biran, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant diseaseZ Gilead, R Zahavi, A Hatzubai, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1983
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinomaA Sulkes, G Brufman, S Rizel, et al.
Anti-Cancer Drugs|April 1, 1993
A preliminary report of a pilot randomized trial comparing cyclophosphamide, methotrexate and 5-fluorouracil with cyclophosphamide, mitoxantrone and 5-fluorouracil in the adjuvant therapy of stage II breast cancer with four or more positive axillary nodesR Isacson, T Safra, C G Ben-Dor, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literatureO Lyass, G Brufman, D Z Edelmann, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oncology|January 1, 1984
Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumorsG Brufman, J Halpern, A Sulkes, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Fetal hemoglobin screening in whole blood and in plasma of cancer patientsM Wolk, M Kieselstein, C G Ben-Dor, et al.
Oncology|January 1, 1989
Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover studyE Gez, R Ben-Yosef, R Catane, et al.
Israel Journal of Medical Sciences|September 1, 1981
Immune complex-like materials in sera of patients with breast cancer: detection by complement-consumption assayD Sulitzeanu, O Asaf, S Biran, et al.
Breast Cancer Research and Treatment|January 1, 1993
The effect of tamoxifen on the endometriumB Uziely, A Lewin, G Brufman, et al.
Cancer|December 15, 1981
Comparison of the response to PHA and suppressor macrophage function in different age groups of cancer patients and healthy controlsA J Treves, A Horowitz, S Biran, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1983
Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant diseaseZ Gilead, R Zahavi, A Hatzubai, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1983
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinomaA Sulkes, G Brufman, S Rizel, et al.
Anti-Cancer Drugs|April 1, 1993
A preliminary report of a pilot randomized trial comparing cyclophosphamide, methotrexate and 5-fluorouracil with cyclophosphamide, mitoxantrone and 5-fluorouracil in the adjuvant therapy of stage II breast cancer with four or more positive axillary nodesR Isacson, T Safra, C G Ben-Dor, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literatureO Lyass, G Brufman, D Z Edelmann, et al.
Pageof 5